chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Contracted skin rash/itches/hives appears and goes anywhere on the body ,mostly  arms, upper body, palms and feet; Contracted skin rash/itches/hives appears and goes anywhere on the body ,mostly  arms, upper body, palms and feet; Contracted skin rash/itches/hives appears and goes anywhere on the body ,mostly  arms, upper body, palms and feet; This spontaneous case was reported by an other health care professional and describes the occurrence of URTICARIA (Contracted skin rash/itches/hives appears and goes anywhere on the body ,mostly  arms, upper body, palms and feet), PRURITUS (Contracted skin rash/itches/hives appears and goes anywhere on the body ,mostly  arms, upper body, palms and feet) and RASH (Contracted skin rash/itches/hives appears and goes anywhere on the body ,mostly  arms, upper body, palms and feet) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In December 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In December 2021, the patient experienced URTICARIA (Contracted skin rash/itches/hives appears and goes anywhere on the body ,mostly  arms, upper body, palms and feet), PRURITUS (Contracted skin rash/itches/hives appears and goes anywhere on the body ,mostly  arms, upper body, palms and feet) and RASH (Contracted skin rash/itches/hives appears and goes anywhere on the body ,mostly  arms, upper body, palms and feet). The patient was treated with CORTISONE for Adverse event, at an unspecified dose and frequency and FEXOFENADINE HYDROCHLORIDE (ALLEGRA [FEXOFENADINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, URTICARIA (Contracted skin rash/itches/hives appears and goes anywhere on the body ,mostly  arms, upper body, palms and feet), PRURITUS (Contracted skin rash/itches/hives appears and goes anywhere on the body ,mostly  arms, upper body, palms and feet) and RASH (Contracted skin rash/itches/hives appears and goes anywhere on the body ,mostly  arms, upper body, palms and feet) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported by reporter. Treatment activities for event was also done with anti itch cream and it helped. The events had been ongoing for two weeks.
Per clients sister:  dime size redness at injection site with serous fluid filled blister same circumference as redness that was noted evening of injection day (10/03/2019) by clients mother.  Client's sister said she saw area morning of 10/04/2019 and fluid filled blister broke  that same day (10/04/2019).  States area has since healed and is not causing any problems.  Client did not seek medical care for area
Loose cough (getting to be more productive); Sneezing; Dry cough; Sore arm; Hip Pain; Muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), COUGH (Dry cough), PRODUCTIVE COUGH (Loose cough (getting to be more productive)), SNEEZING (Sneezing) and ARTHRALGIA (Hip Pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), ARTHRALGIA (Hip Pain) and MYALGIA (Muscle aches). On 26-Feb-2021, the patient experienced COUGH (Dry cough). On 02-Mar-2021, the patient experienced PRODUCTIVE COUGH (Loose cough (getting to be more productive)) and SNEEZING (Sneezing). The patient was treated with DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) ongoing since an unknown date at an unspecified dose and frequency and DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE (DAYQUIL) ongoing since an unknown date at an unspecified dose and frequency. On 26-Feb-2021, PAIN IN EXTREMITY (Sore arm), ARTHRALGIA (Hip Pain) and MYALGIA (Muscle aches) had resolved. At the time of the report, COUGH (Dry cough), PRODUCTIVE COUGH (Loose cough (getting to be more productive)) and SNEEZING (Sneezing) outcome was unknown.            No relevant concomitant medications were reported.   This case was linked to MOD-2021-032313 (Patient Link).
brief lt hand intention tremor, fussy & crying x 7 1/2hr;temp max 101;on exam @ 8hr p/vax & 15min p/tremor, fussy but consolable & nl exam-otherwise shot site no tender not red or indurated;
3/29/2021 Pfizer COVID vaccine #1.  Reports feeling poorly since that day. 4/3/2021 ED visit for complaint of SOB, fever, body aches.  Admitted for sepsis. 4/4 intubated. 4/12 extubated. 4/14 remains hospitalized. Workup negative for infectious cause.  Oncologist consulted, does not appear cancer related.  MD suspects reaction to vaccine.
Patient came on 12/2/21 for second COVID19 vaccine. He was accidentally given adult dose from 12/1/21 (unrefrigerated overnight). Discussed with mom right after it was administered. Reviewed potential risk for additional or more severe side effects (most likely arm pain, fatigue, headaches). Can give Motrin or Tylenol. Will have him return in 3 weeks to get second dose of 5-11 year old Pfizer. Mom agreeable to plan. Mother of Child called on 12/3/21 with concerns of patient starting to feel numbness on both of his legs and feet, fatigue, fever, and just "looking out of it." She states that yesterday he just had a fever and felt weak which she knows would be a side effect of the COVID vaccine. Per physician schedule for apt today. Mother of child called shortly after and stated she would be taking the child to the ED.
Vaccine was given Intramuscularly and not Subcutaneously.  No reaction, no incident. No need to re-inject.
Swelling, red, rash, urticaria, hives (R) arm, HA.
Within 24 hours, the child's grandmother noticed that his left arm became red and swollen.  The child did not complain of any other symptoms.  His MD recommended Benadryl 1 25mg three times a day.
Left arm pain at injection shot; Tiredness; Headache; All over muscle aches; Received moderna vaccine as dose 1 and  BNT162B2 as dose 2; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 12Mar2021 at 15:00 (at the age of 67-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma and cancer diagnosis 20 years ago and have been in remission since 2001. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received acetylsalicylic acid (ASPIRIN) for unknown indication on an unknown date and experienced drug allergy. The patient previously received the first dose of COVID-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE) in the left arm on 19Feb2021 for immunisation. On 12Mar2021 at 23:00, the patient experienced left arm pain at injection shot, tiredness, headache, and muscle aches all over. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events left arm pain at injection shot, tiredness, headache, and all over muscle aches were not recovered at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report was received from an unspecified person on behalf of an unknown age female patient as part of patient support program. Pertinent medical history, drug reactions or allergies were not reported. On an unknown date, the patient was vaccinated with ZOSTAVAX (dose, route and lot number were not reported). Concomitant medication was not reported. On an unknown date, the patient experienced headaches and a sore arm right after receiving ZOSTAVAX. The outcome of the patient experiencing headaches and a sore arm was unknown. Causality was not reported. Additional information is not expected.
numbness over both sides of the face; tingling over both sides of the face; tingling on the left side of the body; numbness on the left side of the body/numbness over the right side of the body; tingling over the right side of the body/tingling over both sides of the face; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling on the left side of the body), HYPOAESTHESIA (numbness on the left side of the body/numbness over the right side of the body), PARAESTHESIA (tingling over the right side of the body/tingling over both sides of the face), HYPOAESTHESIA (numbness over both sides of the face) and PARAESTHESIA (tingling over both sides of the face) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 008B21A) for COVID-19 vaccination.     No Medical History Information was reported.  Concomitant products included METFORMIN, METOPROLOL TARTRATE, APIXABAN (ELIQUIS), CITALOPRAM, HYDROCHLOROTHIAZIDE, OLMESARTAN MEDOXOMIL (OLMESARTAN MEDOXOMIL/HYDROCHLOROTHIAZIDE KRKA), SITAGLIPTIN PHOSPHATE (JANUVIA [SITAGLIPTIN PHOSPHATE]), OMEPRAZOLE, ATORVASTATIN and FISH OIL for an unknown indication.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Mar-2021, the patient experienced PARAESTHESIA (tingling on the left side of the body), HYPOAESTHESIA (numbness on the left side of the body/numbness over the right side of the body) and PARAESTHESIA (tingling over the right side of the body/tingling over both sides of the face). On 25-Mar-2021, the patient experienced HYPOAESTHESIA (numbness over both sides of the face) and PARAESTHESIA (tingling over both sides of the face). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PARAESTHESIA (tingling on the left side of the body), HYPOAESTHESIA (numbness on the left side of the body/numbness over the right side of the body), PARAESTHESIA (tingling over the right side of the body/tingling over both sides of the face), HYPOAESTHESIA (numbness over both sides of the face) and PARAESTHESIA (tingling over both sides of the face) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications included Olmesartan-medox HCTZ.
Information has been received from an 82-year-old female who "6 or 7 years ago" while enrolled in a clinical trail, in approximately 2000, was vaccinated with a 0.65 ml dose of zoster vaccine live (Oka/Merck). There was no concomitant medication. On 12-OCT-2007 the patient experienced shingles. No medical attention was sought. At the time of this report the patient had not recovered. No product quality complaint was involved. No further information is available.
Pt developed weakness, dizziness, saw white spots before her eyes, had shortness of breath when walking and was nauseated. Pt was treated with fluid and rest and avoidance of stimulants.
Soreness in arms for days; intermediate headaches; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 04Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "allergy with high blood medications" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset Apr2021, outcome "unknown", described as "Soreness in arms for days"; HEADACHE (non-serious) with onset Apr2021, outcome "unknown", described as "intermediate headaches".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Large swelling on left arm with soreness and warmth. Was given Zyrtec and told to apply ice.
High Dose FLUZONE given IM at 1:30pm 10/14/10. At 6pm patient c/o throbbing arm, shakes, BP dropped to 90/54 then 78/49, fever of 102.0.
Prolonged tiredness; increased weakness; dragging right foot when walks; little more trouble swallowing pills than before; little more trouble swallowing pills than before; This is a spontaneous report from a contactable consumer (the patient). A 93-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL1283), via an unspecified route of administration in the right arm on 26Jan2021 09:15 (at the age of 93-years-old) as a single dose for COVID-19 immunization. The patient's medical history included: aortic stenosis, COPD (chronic obstructive pulmonary disease), blood pressure medications, and trouble swallowing pills. The patient was not pregnant at the time of vaccination. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had unspecified concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Jan2021, the patient experienced prolonged tiredness, increased weakness, dragging right foot when walks, little more trouble swallowing pills than before. No treatment was received for the events. The clinical outcome of the event was not recovered. It was also reported that since the vaccination, the patient had not been tested for COVID-19.
Approximately 5 hours after receiving flu shot, I came down with fever and body aches. The next day still had same problem with heavy drainage, weakness and headaches and plugs sinus. These symptoms have continued for over 7 days with slow recovery since also during this period, stomach uneasy and loose bowel.
widespread muscle and joint pain, worse in bilateral posterior knee ligaments and bilateral shoulders and bilateral hands, he states that getting out of chair was difficult, Range of motion slightly restricted due to pain and tight muscles, sensation intact, capillary refill normal in all extremities
had the flu; Initial information received on 27-Nov-2020 regarding an unsolicited valid non-serious case from a consumer via Social media.  This case involves an Adult patient (gender unknown) who experienced had the flu (influenza), while the patient received INFLUENZA VACCINE [INFLUENZA VACCINE].  Medical history, medical treatment, vaccination and family history were not provided.    On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number: not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, after started vaccine, the patient got a flu shot went to physician said the patient had the flu (influenza). The physician said that why you got the flu the doctor said he does not recommend no 1 to get the flu shot.  No laboratory data was provided.  Final diagnosis was influenza.   It was not reported if the patient received a corrective treatment.  The outcome was reported as Unknown for flu.
Spotting/bleeding two weeks into the first shot; This is a spontaneous report from a contactable consumer.   A 26-year-old female patient received first dose of bnt162b2 (BNT162B2), via an unspecified route of administration, administered in Right Arm on 22Apr2021 17:00 (Lot Number: En0172) as 1ST DOSE, SINGLE for covid-19 immunisation.  The patient's medical history and concomitant medications were not reported. Prior to vaccination, the patient has not been diagnosed with COVID-19 On 08May2021, patient experienced spotting/bleeding two weeks into the first shot. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the event was unknown. No treatment was received.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Development of non-tender red spots (enanthem) on soft palate; ~12 hours after the vaccination. Other symptoms included fatigue. No other rash anywhere on the skin. Rash spontaneously fading over the next 36-48 hours.
Anaphylactic reaction - Right arm red from shoulder radiation down to wrist. Difficulty breathing.
Developed redness, swelling, streaking, warmth to site of injection - spread to axillary area.  Had chills.  No fever.
Left arm injection site swelling, induration 1. 5" tender, erythematous rash, with mild tingling (L) upper extremity, headache and tiredness x 3 days. Cold compress, OTC NSAIDS. Raise extremity on pillow. Go to ER with symptom worsening.
c/o hives, SOB, severe itching, lt side abd pain;kidneys not working like they should;tx for allerg rxn reported by MD office;given DPH, adrenaline & medrol pack;instructed to return to MD office or ER if sx reoccur;
I started getting fatigued around 7:00 pm that evening. It was hard to finish walking my dog. I was getting the chills to the point that my teeth were chattering.  I couldn't wear a shirt at this point because it felt like sandpaper on my back, but I did not have a rash.  I went to bed earlier than normal and woke up around 11:30 with the worst headache of my life.  My head was throbbing and pulsating and any little movement made it worse. The bottom of my head hurt, where my head connects to my neck.  My lower back hurt.  I woke up every 1 1/2 hours in pain, due to terrible headache.  After suffering for several hours, I finally took some Aleve at 7:00 a.m. the morning following the vaccine.
I had an extremely itchy throat and sinus headache. I took a home COVID-19 test that came back negative, so I went to my doctor's office. Upon examination my doctor said he felt that it may be my seasonal allergies, he did prescribe an antibiotic just in case I was getting an infection. I am feeling better, I am experiencing some itchy eyes, but I believe that may be allergy related.
Patient was at the vaccination clinic where both Moderna Spikevax and Fluad were available for administration, patient wanted Moderna Spikevax only,  but the Fluad HD was given instead in right deltoid.  Patient had already received Fluad HD September 2023 at unknown location.  Patient was given Moderna Spikevax in left deltoid.
Pt recvd vax 15JUL92 & 20JUL92 c/o sore throat, joint pains, axillary swelling & fever; pt was told that had exacerbation of blood pressure elevation & that diabetes was out of control; No further details were provided;
No physical adverse effects: Patient was given what was believed to be his first injection of MENACTRA today in our clinic. After patient left and this RN was transcribing off copied card it was found that a Meningococcal injection had been charted under polio on patients very full card. This patient received MENACTRA injection at another facility on 7/25/2011. So it has only been 1 yr 1 month since patients last dose of this immunization. MD called the number listed for the CDC who asked that we also fill out a form on line with question as to possibility of ill effect. No known problem from this second injection today per what MD was told. Suggest that when transcribing on immunization card that immunizations not be "fit" into any space on card. This would help stop this.
Information has been received from a registered nurse concerning a 4 year old female with no known allergies or pertinent medical history who on 09-MAY-2007 was inadvertantly vaccinated SC with a dose of Zostavax (lot # 656606/0033U) instead of MMRV. Concomitant vaccination included a dose of diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid (manufacturer unknown), poliovirus vaccine (manufacturer unknown) and Prevnar. Unspecified medical attention was sought. The patient had no symptoms or adverse effects. There were no lab tests performed. There was no product quality complaint involved. No further information was provided. Additional information has been requested. This is one of several reports from the same source. This is in follow-up to report (s) previously submitted on 6/14/2007. Additional information has been received from the registered nurse who stated tht the error occurred because the bottles of the vaccines were kept in the same place and they looked similar. It was reported that now they are store vaccines seperately to prevent the product confusion. The vaccination of patient and her sibling. No further information is available. This one of several reports from the same source.
Patient received Tdap on 3-30-17. On 5-15-17 patient called and reported redness and swelling at injection site. Was scheduled to be seen by provided on 5-17-17. Diagnosed with cellulitis at site on injection and prescribed cephalexin 500 mg 1 every 6 hr x 7 days.
achiness in arm; arm rigidity/ unable to move the arm; This case was reported by a nurse via sales rep and described the occurrence of pain in arm in a 59-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of injection site pain (experienced after 1st dose, refer linked case US2019GSK077075).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, immediately after receiving Shingrix, the patient experienced pain in arm and injected limb mobility decreased. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the pain in arm and injected limb mobility decreased were unknown.   It was unknown if the reporter considered the pain in arm and injected limb mobility decreased to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. Almost immediately, after vaccination with 2nd dose, the patient experienced achiness. Over the course of days, the patient unable to move the arm. The patient was seen in office on 12th April 2019, Friday and was given with medicine for arm. The patient was going to be seen again on 15th April 2019 for follow up. The clinic was submitting the VAERS.